Skip to main content
Premium Trial:

Request an Annual Quote

Roche Discovery Chief Brown Will Head Cellzome

NEW YORK, Sept. 16-Cellzome has hired Roche discovery chief David Brown as president and chief executive officer, the company said today.


Brown will help guide the company as it progresses into drug development, former CEO Charles Cohen said in a statement.


He was previously global head of discovery at Roche, where he oversaw drug candidate development, in-licensing and acquisitions. Previously, at Pfizer, Brown was involved in developing Viagra.


Cohen will now chair Cellzome's supervisory board.


Cellzome's core research is in functional proteomics. The company plans to move into drug development by creating treatments for neurological disease, cancer, metabolic disorders and inflammation-related disease. It is based in Heidelberg, Germany.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.